Prevalence and characterization of extended-spectrum β-lactamase-producing Enterobacteriaceae isolated in Korean hospitals

Diagnostic Microbiology and Infectious Disease

Volumn 61, Issue 4, 2008, Pages 453-459

  Ko, Kwan Soo ^a,b   Lee, Mi Young ^b   Song, Jae Hoon ^a,b   Lee, Hyuck ^c   Jung, Dong Sik ^c   Jung, Sook In ^d   Kim, Shin Woo ^e   Chang, Hyun Ha ^e   Yeom, Joon Sup ^f   Kim, Yeon Sook ^g   Ki, Hyun Kyun ^h   Chung, Doo Ryeon ^a   Kwon, Ki Tae ⁱ   Peck, Kyong Ran ^a   Lee, Nam Yong ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Asia Pacific Foundation for Infectious Diseases (APFID)   (South Korea)

^c Dong A University College of Medicine   (South Korea)

^d Chonnam National University Medical School   (South Korea)

^e Kyungpook National University Hospital   (South Korea)

^f Sungkyunkwan University School of Medicine   (South Korea)

^g Chungnam National University College of Medicine   (South Korea)

^h Konkuk University Hospital   (South Korea)

ⁱ Daegu Fatima Hospital   (South Korea)

Author keywords

Escherichia coli; Extended spectrum lactamases (ESBLs); Klebsiella pneumoniae

Indexed keywords

EXTENDED SPECTRUM BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLOOD; CITROBACTER FREUNDII; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ENZYME SYNTHESIS; ESCHERICHIA COLI; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; KOREA; MORGANELLA MORGANII; PREVALENCE; PRIORITY JOURNAL; PROTEUS MIRABILIS; PROTEUS VULGARIS; PROVIDENCIA; PUS; SERRATIA MARCESCENS; SPUTUM; TERTIARY HEALTH CARE; URINE;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; BLOOD; DNA, BACTERIAL; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; HOSPITALS; HUMANS; KLEBSIELLA PNEUMONIAE; KOREA; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA; SPUTUM; SUPPURATION; URINE;

EID: 47049104777     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2008.03.005     Document Type: Article

References (27)

1. Bradford P.A. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol Rev. 14 (2001) 933-951
2. Cardoso O., Alves A.F., and Leitão R. Metallo-β-lactamase VIM-2 in Pseudomonas aeruginosa isolates from a cystic fibrosis patient. Int. J. Antimicrob. Agents 31 (2008) 375-379
3. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 16th informational supplement. Document M100-S16 (2006), CLSI, Wayne, PA
4. Cosgrove S.E. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin. Infect Dis. 42 Suppl 2 (2006) S82-S89
5. Hirakata Y., Matsuda J., Miyazaki Y., Kamihira S., Kawakami S., Miyazawa Y., Ono Y., Nakazaki N., Hirata Y., Inoue M., Turnidge J.D., Bell J.M., Jones R.N., Kohno S., and the SENTRY Asia-Pacific participants. Regional variation in the prevalence of extended-spectrum β-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002). Diagn. Microbiol. Infect Dis. 52 (2005) 323-329
6. Hyle E.P., Lipworth A.D., Zaoutis T.E., Nachamkin I., Fishman N.O., Bilker W.B., Mao X., and Lautenbach E. Risk factors for increasing multidrug resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species. Clin. Infect Dis. 40 (2005) 1317-1324
7. Jacoby G.A., and Munoz-Price L.S. The new β-lactamases. N. Engl. J. Med. 352 (2005) 380-391
8. Jeong S.H., Bae I.K., Lee J.H., Sohn S.G., Kang G.H., Jeon G.J., Kim Y.H., Jeong B.C., and Lee S.H. Molecular characterization of extended-spectrum β-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli from a Korean nationwide survey. J. Clin. Microbiol. 42 (2004) 2902-2906
9. Jeong S.H., Bae I.K., Kwon S.B., Lee J.H., Jung H.I., Song J.S., Jeong B.C., Kim S.J., and Lee S.H. Investigation of extended-spectrum β-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli in Korea. Lett. Appl. Microbiol. 39 (2004) 41-47
10. Jeong S.H., Bae I.K., Kwon S.B., Lee J.H., Song J.S., Jung H.I., Sung K.H., Jang S.J., and Lee S.H. Dissemination of transferrable CTX-M-type extended-spectrum β-lactamase-producing Escherichia coli in Korea. J. Appl. Microbiol. 98 (2005) 921-927
11. Kim J., and Lim Y.M. Prevalence of derepressed AmpC mutants and extended-spectrum β-lactamase producers among clinical isolates of Citrobacter freundii, Enterobacter spp., and Serratia marcescens in Korea: dissemination of CTX-M-3, TEM-52, and SHV-12. J. Clin. Microbiol. 43 (2005) 2452-2455
12. Kim J., Kwon Y., Pai H., Kim J.W., and Cho D.T. Survey of Klebsiella pneumoniae strains producing extended-spectrum β-lactamases: prevalence of SHV-12 and SHV-2a in Korea. J. Clin. Microbiol. 36 (1998) 1446-1449
13. Kim J., Lim Y.M., Rheem I., Lee Y., Lee J.C., Seol S.Y., Lee Y.C., and Cho D.T. CTX-M and SHV-12 β-lactamases are the most common extended-spectrum enzymes in clinical isolates of Escherichia coli and Klebsiella pneumoniae collected from 3 university hospitals within Korea. FEMS Microbiol Lett. 245 (2005) 93-98
14. Ko K.S., Suh J.Y., Peck K.R., Lee M.Y., Oh W.S., Kwon K.T., Jung D.S., Lee N.Y., and Song J.H. In vitro activity of fosfomycin against ciprofloxacin-resistant or extended-spectrum β-lactamase-producing Escherichia coli isolated from urine and blood. Diagn. Microbiol Infect Dis. 58 (2007) 111-115
15. Ko K.S., Yeom J.S., Lee M.Y., Peck K.R., and Song J.H. Clonal dissemination of extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae isolates in a Korean hospital. J. Kor. Med. Sci. 23 (2008) 53-60
16. Kolar M., Latal T., Cermak P., Bartonikova N., Chmelarova E., Sauer P., Kesselova M., and on behalf of the research group. Prevalence of extended-spectrum β-lactamase-positive Klebsiella pneumoniae isolates in the Czech Republic. Int. J. Antimicrob. Agents. 28 (2006) 49-53
17. Lautenbach E., Patel J.B., Bilker W.B., Edelstein P.H., and Fishman N.O. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin. Infect Dis. 32 (2001) 1162-1171
18. Pai H., Lyu S., Lee J.H., Kim J., Kwon Y., Kim J.W., and Choe K.W. Survey of extended-spectrum β-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence of TEM-52 in Korea. J. Clin. Microbiol. 37 (1999) 1758-1763
19. Park Y.J., Park S.Y., Oh E.J., Park J.J., Lee K.Y., Woo G.J., and Lee K. Occurrence of extended-spectrum β-lactamases among chromosomal AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens in Korea and investigation of screening criteria. Diagn. Microbiol. Infect Dis. 51 (2005) 265-269
20. Pasterán F., Rapoport M., Petroni A., Faccone D., Corso A., Galas M., Vázquez M., Procopio A., Tokumoto M., and Cagnoni V. Emergence of PER-2 and VEB-1a in Acinetobacter baumannii strains in the Americas. Antimicrob. Agents Chemother. 50 (2006) 3222-3224
21. Paterson D.L., and Bonomo R. Extended-spectrum β-lactamases: a clinical update. Clin. Microbiol. Rev. 18 (2005) 657-686
22. Pena C., Pujol M., Ardanuy C., Ricart A., Pallares R., Linares J., Ariza J., and Gudiol F. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum β-lactamases. Antimicrob. Agents Chemother. 42 (1998) 53-58
23. Ruppé E., Bidet P., Verdet C., Arlet G., and Bingen E. First detection of the Ambler class C 1 AmpC β-lactamase in Citrobacter freundii by a new, simple double-disk synergy test. J. Clin. Microbiol. 44 (2006) 4204-4427
24. Ryoo N.H., Kim E.C., Hong S.G., Park Y.J., Lee K., Bae I.K., Song E.H., and Jeong S.H. Dissemination of SHV-12 and CTX-M-type extended-spectrum β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea. J. Antimicrob. Chemother. 56 (2005) 698-702
25. Schwaber M.J., Raney P.M., Rasheed J.K., Biddle J.W., Williams P., McGowan Jr. J.E., and Tenover F.C. Utility of NCCLS guidelines for identifying extended-spectrum β-lactamases in non-Escherichia coli and non-Klebsiella spp. of Enterobacteriaceae. J. Clin. Microbiol 42 (2004) 294-298
26. Villegas M.V., Correa A., Perez F., Miranda M.C., Zuluaga T., Quinn J.P., and the Colombian Nosocomial Resistance Study Group. Prevalence and characterization of extended-spectrum β-lactamases in Klebsiella pneumoniae and Escherichia coli isolates from Colombian hospitals. Diagn. Microbiol. Infect Dis. 49 (2004) 217-222
27. Wu T.L., Chia J.H., Su L.H., Chu C., Kuo A.J., and Chiu C.H. Dissemination of extended-spectrum β-lactamase-producing Enterobacteriaceae in intensive care units of a medical center in Taiwan. Microb. Drug. Resist. 12 (2006) 203-209